NIH in the Post-Doubling Era: Realities and Strategies

摘要

This has been a challenging year for the National Institutes of Health (NIH) and the biomedical research community. An extraordinarily tight federal budget is eroding the growth of NIH at a time when opportunities for scientific progress and advancesin human health have never been greater. As I talk to scientists and administrators throughout the country, the anxiety is palpable. I share these concerns. I am most deeply troubled about the impact of this difficult situation on junior scientists, andon the ability of established investigators to maintain their laboratories.